The American Society of Gene Therapy (ASGT) is a non-profit medical and professional organization that represents researchers and scientists devoted to the discovery of new gene therapies. ASGT was established in 1996 by Dr. George Stamatoyannopoulos, professor of medicine at the University of Washington 's School of Medicine and a group of the country's leading researchers in gene therapy. With more than 2,000 members in the United States and worldwide, ASGT is the largest association of individuals involved in gene therapeutics. The Society's Executive Office is located in Milwaukee, WI.
Governed by its officers and board of directors, ASGT has nine standing committees, including Clinical/Regulatory Affairs, Ethics, Education, Membership, Program, and Public Education and Outreach; and 14 scientific committees that focus on disease-specific issues such as cancer, cardiovascular, genetic, musculo-skeletal, infectious, and neural degenerative disorders.
| Contact Details: |
| 555 East Wells StreetSuite 1100 |
| Milwaukee |
| Wisconsin |
| 53202 |
| United States of America |
| Tel: | 414.278.1341 |
| Fax: | 414.276.3349 |
| Email: | info@asgt.org |
| WWW: | www.asgt.org/
|
|
Loading...
|
Press Releases on American Society of Gene Therapy:
|
 |
| Video: One Shot of Gene Therapy and Children with Congenital Blindness Can Now See |
24th October, 2009 |
|
PHILADELPHIA, October 24 /PRNewswire/ -- Born with a retinal disease that made him legally blind, and would
eventually leave him totally sightless, the nine-year-old boy used to sit in
the back of the
|
| Senesco Technologies Reports Fiscal Year 2009 Financial Results |
29th September, 2009 |
Senesco Technologies, Inc. |
-- Data from Senesco's multiple myeloma-focused preclinical studies were
presented at the 2008 Annual Meeting of the American Society of
Hematology and at the American
|
| Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting |
28th May, 2009 |
Celladon Corporation |
Phase 1 Data Demonstrate Safety and Evidence of Biological Activity in 9 of 12 Patients;
Phase 2 Study Currently Enrolling in 17 Leading U.S. Medical Centers
SAN DIEGO, May 28 /PRNewswire/ --
|
| Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting |
28th May, 2009 |
Cardium Therapeutics |
SAN DIEGO, May 28 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) and its subsidiary Tissue Repair Company (TRC) today announced a presentation entitled "Phase 2b Study of GAM501
|
| Senesco Presents Pre-Clinical Multiple Myeloma Data at the 12th Annual Meeting of the American Society of Gene Therapy |
27th May, 2009 |
Senesco Technologies, Inc. |
NEW BRUNSWICK, N.J., May 27 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Amex: SNT) announced today that Richard Dondero, Vice
|
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 354 times since April 2007, the link to the organisation's website has been followed 56 times
Recent Search Terms used to find this page: ASGT MEETING IN SAN DIEGO | gene therapy hiv ASGT | Am Soc Gene Therapy | .
Search for more companies in Milwaukee
Search for more companies in Wisconsin
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
American Society of Gene Therapy
